Form 4: Teladoc Health Executive Michael Waters Acquires 87,500 Restricted Stock Units

Teladoc Health's Chief Operating Officer, Michael Willem Waters, was granted 87,500 restricted stock units (RSUs) on March 19, 2024, according to a Form 4 filing with the SEC.

Summary

• On March 19, 2024, Michael Willem Waters, the Chief Operating Officer of Teladoc Health, Inc. (TDOC), acquired 87,500 restricted stock units (RSUs).
• Each RSU represents a contingent right to receive one share of TDOC common stock.
• The RSUs vest over time, with one-third vesting on the first anniversary of the grant date.
• The remaining RSUs vest in eight substantially equal quarterly installments beginning on June 1, 2025.
• Following the transaction, Waters directly owns 87,500 derivative securities.

Sentiment

Score: 5

Explanation: This is a routine disclosure of stock unit grants, neither particularly positive nor negative.

Industry Context

Form 4 filings are routine disclosures for corporate insiders and are a standard part of corporate governance and transparency.

Stakeholder Impact

• The grant of RSUs aligns management's interests with those of shareholders, as the value of the RSUs is tied to the company's stock performance.

Key Dates